SCM
Silverarc Capital Management Portfolio holdings
AUM
$489M
This Quarter Return
+1.14%
1 Year Return
+71.55%
3 Year Return
+1,109.63%
5 Year Return
–
10 Year Return
–
AUM
$205K
AUM Growth
+$205K
(-100%)
Cap. Flow
-$38.7M
Cap. Flow
% of AUM
-18,901.35%
Top 10 Holdings %
Top 10 Hldgs %
33.05%
Holding
123
New
32
Increased
38
Reduced
21
Closed
29
Top Buys
| 1 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
$12.8K |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$5.29K |
| 3 |
MacroGenics
MGNX
|
$4.75K |
| 4 |
ELOX
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
|
$3.76K |
| 5 |
Veracyte
VCYT
|
$3.63K |
Top Sells
| 1 |
Vericel Corp
VCEL
|
$6.78M |
| 2 |
MSACU
Medicus Sciences Acquisition Corp. Unit
MSACU
|
$4.01M |
| 3 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$2.87M |
| 4 |
Larimar Therapeutics
LRMR
|
$2.8M |
| 5 |
ESSA Pharma
EPIX
|
$2.13M |
Sector Composition
| 1 | Healthcare | 86.9% |
| 2 | Financials | 6.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Seres Therapeutics
MCRB
$166M
| $1.52K | 0.68% | 63,915 -36,085 | -36% | -$860 |
|
52
RAPT Therapeutics
RAPT
$188M
| $1.5K | 0.67% | +47,194 | New | +$1.5K |
|
53
Relmada Therapeutics
RLMD
$37.2M
| $1.5K | 0.67% | +46,729 | New | +$1.5K |
|
|
ARNA
54
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.4K | 0.63% | 20,577 +577 | +3% | +$39 |
|
55
PolyPid
PYPD
$53.3M
| $1.4K | 0.62% | 154,566 +4,740 | +3% | +$43 |
|
|
DCPH
56
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $1.36K | 0.61% | 37,257 -2,508 | -6% | -$92 |
|
|
RETA
57
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $1.32K | 0.59% | +9,346 | New | +$1.32K |
|
|
MREO
58
Mereo BioPharma
MREO
$272M
| $1.29K | 0.57% | 405,871 +230,871 | +132% | +$732 |
|
59
Delcath Systems
DCTH
$385M
| $1.25K | 0.56% | 99,189 +59,189 | +148% | +$746 |
|
60
Evogene
EVGN
$10.9M
| $1.24K | 0.55% | 361,254 +11,254 | +3% | +$38 |
|
61
Athira Pharma
ATHA
$15.3M
| $1.21K | 0.54% | +117,980 | New | +$1.21K |
|
|
TRIL
62
DELISTED
Trillium Therapeutics Inc.
TRIL
| $923 | 0.41% | 95,190 +35,190 | +59% | +$341 |
|
|
SGEN
63
DELISTED
Seagen Inc. Common Stock
SGEN
| $905 | 0.4% | 5,732 +732 | +15% | +$116 |
|
64
Wave Life Sciences
WVE
$1.53B
| $826 | 0.37% | 123,972 +83,972 | +210% | +$560 |
|
65
Akero Therapeutics
AKRO
$3.74B
| $819 | 0.37% | 33,028 +1,028 | +3% | +$25 |
|
66
Ardelyx
ARDX
$1.53B
| $752 | 0.34% | 99,237 +54,237 | +121% | +$411 |
|
67
Ascendis Pharma
ASND
$11.8B
| $737 | 0.33% | 5,599 -13,095 | -70% | -$1.72K |
|
|
SURF
68
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $705 | 0.31% | 94,539 -5,461 | -5% | -$41 |
|
|
BLU
69
DELISTED
BELLUS Health Inc.
BLU
| $653 | 0.29% | +209,933 | New | +$653 |
|
|
ODT
70
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $652 | 0.29% | 186,680 -313,320 | -63% | -$1.09K |
|
|
VRAY
71
DELISTED
ViewRay, Inc.
VRAY
| $623 | 0.28% | +94,388 | New | +$623 |
|
72
Syndax Pharmaceuticals
SNDX
$1.41B
| $596 | 0.27% | 34,727 +14,727 | +74% | +$253 |
|
73
Guardant Health
GH
$8.41B
| $580 | 0.26% | 4,673 -5,519 | -54% | -$685 |
|
74
Cerus
CERS
$251M
| $528 | 0.24% | +18,691 | New | +$528 |
|
75
89bio
ETNB
$1.34B
| $524 | 0.23% | 28,032 -21,975 | -44% | -$411 |
|